FDA Updates Labeling for Nilotinib: Treatment Can Be Stopped FDA Updates Labeling for Nilotinib: Treatment Can Be Stopped

The FDA has updated labeling for nilotinib, specifying that for certain patients in long-term remission, treatment can be stopped.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news